Posted
Website Clinical Forum
We have launched an online Clinical Forum which is available on the Ashtons Hospital Pharmacy website. It is available for all clinical staff, from any discipline, and we invite staff from all [...]
In Improving Compliance, Medicines Management Processes, New Ashtons Services, New Product, Simplifying Product Supply
Posted Emergency Drugs Box Replenishment and Bespoke Labelling
We have recently developed a computerised database of the contents of all our hospitals’ emergency drugs boxes and now have a new system which enables us to pre-order the required emergency [...]
In Medicines Management Processes, Mental Health, New Ashtons Services, New Product, Pharmacy Information
Posted Medicines: A Patient Profile Summary (MaPPs)
MaPPs is an innovative new service that produces a summary of ALL of a patient’s medication in electronic format which can be used in a variety of ways. The main feature of MaPPs is that [...]
Posted
Ashtons Controlled Drugs Training Seminar
The Controlled Drug (Supervision of management and use) Regulations 2013, which came into force in England & Scotland from April 2013, require that all staff who are involved with [...]
NICE Clinical Guideline – Antisocial behaviour and conduct disorders in children and young people: recognition, intervention & management (CG 158)
Conduct disorders, and associated antisocial behaviour, are the most common mental and behavioural problems in children and young people, with a prevalence of 5% between ages 5 and 16 years. [...]
NICE Clinical Guideline – Psychosis and Schizophrenia in children and young people (CG 155)
This guideline is concerned with the recognition and management of psychosis and schizophrenia in children and young people up to age 18. Prognosis is worse when onset of psychosis or [...]
MHRA e-learning module on Benzodiazepines
The MHRA have launched an e-learning module on Benzodiazepines in their series about reducing risks associated with medicines. For the different adverse effects, the module outlines: The main [...]
Posted
Controlled Drug (Supervision of management and use) Regulations 2013
Changes to CD regulations have been made to reflect the new NHS restructuring, and they came into force in England & Scotland from April 2013. There have been significant changes regarding [...]
SIGN 131: Management of Schizophrenia
The Scottish Intercollegiate Guidelines Network (SIGN) have produced treatment guidelines on Schizophrenia which are an additional evidence-based resource for clinical staff. For further [...]
